Cambridgeshire, UK, 22 January 2014 ...
Lumora, a successful provider of state-of-the-art molecular diagnostic products into both the clinical and industrial markets, is pleased to announce that it has appointed Hayden Jeffreys to its Board of Directors.
Hayden joined Lumora from Lab21 in January 2013 as Commercial Director, and since joining Lumora, Hayden has been instrumental in securing a number of deals with global companies and organisations. Hayden has also been responsible for marketing Lumora’s latest invention known as “Heat Elution”, Lumora’s patented sample preparation technology, which significantly reduces the time and complexity involving in testing samples. Prior to Lab21, Hayden held positions at Invitron, Gen-Probe and Molecular Light Technology.
Laurence Tisi, CEO of Lumora said: “Hayden has been a fantastic addition to the team. His commercial knowledge coupled with the scientific excellence of the team has enabled us to close a number of key commercial deals, which have significantly strengthened the company. Hayden’s appointment to the board is richly deserved and his ability, dedication and hard work will be instrumental to Lumora’s continued success.”
For further information please contact:
Tony Stephenson, Director
Tel: +44 (0)7899 796655
Notes to Editors:
Lumora is a successful provider of state-of-the-art molecular diagnostic products into both the clinical and non clinical or industrial markets. Lumora’s easy to deploy and use technology can be employed in fields as diverse as food safety testing, and medical diagnostics. The Company is active in licensing its technology and development partners include international biotechnology, clinical diagnostic and industrial microbiology companies.
Lumora’s corporate office is based just outside of Cambridge, England. The Company's investors include; Tate Lyle Ventures LP, Cambridge Enterprise (University of Cambridge), and Catapult Venture Managers Ltd.